IR-Center Handelsblatt
Unternehmenssuche:

China Grand Pharmaceutical and Healthcare

News Detail

EQS-News News vom 24.08.2015

CHINA GRAND PHARM: 'Ruizhu' Ranked the 4th on the Ophthalmic Medicines Leaderboard in Tmall


(EQS-News / 24/08/2015 / 14:39 UTC+8)

"Ruizhu" Ranked the 4th on the Ophthalmic Medicines Leaderboard in Tmall

Hong Kong,24th August, 2015

In 2014, the turnover scale of the online pharmacies in China reached up to RMB 7 billion, with growth rate of 62.8%, occupied approx. 0.6% of the overall pharmaceutical market in China. The number of online pharmacies was 150 in 2013 and increased to 246 by 2014. Tmall Pharmacy is one of the famous online pharmacy platforms, from May to December 2015, the turnover of Tmall Pharmacy reached up to approx. RMB528 million, and chemical drugs occupied approx. 32.89%.

"Ruizhu" (Polyvinyl Alcohol Eyedrops) is an anti-fatigue, non-prescription ophthalmic brand of China Grand Pharmaceutical and Healthcare Holdings Limited (Abbreviation: China Grand Pharm), it ranked the 4th on the Ophthalmic Medicines Leaderboard at Tmall Pharmacy, with market share of 8.37%.

China Grand Pharm started to involved in e-commerce in 2014, based on the product characters and market analysis, insert different types of products to the sales channels that fit the most to it, i.e. white collar and teenagers are the frequent users of electronic devices, due to the prolong exposure to electronic devices, some of them might be affected by dry eyes and Xerophthalmia. Since June 2015, China Grand Pharm threw in resources on digital TV in China, including Sohu, Tencent and PPTV, promoting "Ruizhu" (Polyvinyl Alcohol Eyedrops), expecting to use the most efficient and fastest way to promote China Grand Pharm and "Ruizhu" to the potential customer base.

Resources: Menet

Ophthalmic Medicines Leaderboard at Tmall Pharmacy

Rank Product Name Manufacturer Market Share
1 Bendazac Lysine Eye Drops Shapuaisi Pharma 15.65%
2 Compound Aspartate,Vitamin B6 and Dipotassium Glycyrrhetate Eye Drops Mentholatum (China) 15.04%
3 Carboxymethylcellulose Sodium Eye Drops Allergan Pharmaceutical Ireland 9.57%
4 Polyvinyl Alcohol Eye Drops Hubei EBE Co. Ltd 8.37%
5 四味珍層冰硼滴眼液
(Chinese name only)
Jiangxi Zhenshi Ming Pharmaceutical
(江西珍視明藥業有限公司)
 
7.49%
6 Compound Aspartate,Vitamin B6 and Dipotassium Glycyrrhetate Eye Drops Jiangxi Shan Liang Pharmaceutical
(江西閃亮製藥有限公司)
2.97%
7 Compound Sodium Chloride Eye Drops(Ⅱ) Mentholatum (China) 2.58%
8 石斛夜光丸
(Chinese NameOnly)
Tongrentang
 
2.58%
9 Compound Chondroitin Sulfate Eye Drops Bausch+Lomb (China) 2.29%
10 撥雲錠
(Chinese Name Only)
Chuxiong Lao Bo Yun Tang Pharmaceutical
(楚雄老拨云堂药业有限公司)
2.05%


End of Press Release

+++++


Document: http://n.equitystory.com/c/fncls.ssp?u=UNVRCWRBIX
Document title: 'Ruizhu' Ranked the 4th on the Ophthalmic Medicines Leaderboard in Tmall


Key word(s): Miscellaneous

24/08/2015 UTC+8 Dissemination of a Press Release, transmitted by EQS TodayIR - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Media archive at www.todayir.com


388751  24/08/2015 UTC+8